Invesco’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
343,659
+6,706
| +2% | +$22.8K | ﹤0.01% | 2781 |
|
|
2025
Q1 | $1.35M | Buy |
336,953
+9,893
| +3% | +$39.7K | ﹤0.01% | 2700 |
|
|
2024
Q4 | $2.12M | Sell |
327,060
-5,845
| -2% | -$37.9K | ﹤0.01% | 2588 |
|
|
2024
Q3 | $1.84M | Buy |
332,905
+12,434
| +4% | +$68.9K | ﹤0.01% | 2633 |
|
|
2024
Q2 | $1.79M | Sell |
320,471
-31,373
| -9% | -$175K | ﹤0.01% | 2622 |
|
|
2024
Q1 | $2.36M | Buy |
351,844
+26,235
| +8% | +$176K | ﹤0.01% | 2575 |
|
|
2023
Q4 | $2.97M | Sell |
325,609
-66,082
| -17% | -$603K | ﹤0.01% | 2469 |
|
|
2023
Q3 | $2.16M | Buy |
391,691
+19,145
| +5% | +$106K | ﹤0.01% | 2560 |
|
|
2023
Q2 | $3.18M | Buy |
372,546
+250,243
| +205% | +$2.14M | ﹤0.01% | 2456 |
|
|
2023
Q1 | $1.12M | Buy |
122,303
+73,992
| +153% | +$680K | ﹤0.01% | 2846 |
|
|
2022
Q4 | $493K | Sell |
48,311
-4,766
| -9% | -$48.7K | ﹤0.01% | 3253 |
|
|
2022
Q3 | $781K | Buy |
53,077
+416
| +0.8% | +$6.12K | ﹤0.01% | 3004 |
|
|
2022
Q2 | $565K | Buy |
52,661
+12,561
| +31% | +$135K | ﹤0.01% | 3250 |
|
|
2022
Q1 | $432K | Buy |
+40,100
| New | +$432K | ﹤0.01% | 3436 |
|